Last month, the total COVID-19 vaccine doses administered in India crossed the 100 crore mark. (Proceedings)
New Delhi, India: India on Tuesday recorded its lowest daily Covid cases in 250 days and the country reported 10,423 cases. However, 443 virus-related deaths were also recorded during the same period.
At least 15,021 people have recovered in 24 hours. The total number of people who have recovered is 3,36,83,581.
Active cases represent less than one percent of total cases, currently 0.45 percent.
The number of active cases is 1,53,776, which is the lowest in 250 days. The weekly positivity rate of 1.16 percent is less than 2 percent for the past 39 days.
READ MORE: Afghan Talks: Won’t Go To India Next Week, Says Pak NSA.
The 1.03 percent daily positivity rate is less than two percent for the past 29 days.
Last month, the total COVID-19 vaccine doses administered in India crossed the 100 crore mark.
Punjab reported 15 new coronavirus cases on Tuesday, bringing the infection count to 6,02,434, according to a medical bulletin.
No Covid-related deaths were reported in the state. The death count, which included a previously unreported case of death, stood at 16,561, according to the bulletin.
The research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 and disease. original from SARS.
The antibody was identified by a team from the Duke Human Vaccine Institute (DHVI) and tested in animal models at UNC-Chapel Hill.
“This antibody has the potential to be therapeutic for the current epidemic,” said co-lead author Barton Haynes, MD, director of DHVI. “It could also be available for future outbreaks, if or when other coronaviruses jump from their natural animal hosts to humans.”
Eric is a professional news editor, writer, and blogger for the last 10 years. He is working with NewsGater as an off-beat news editor cum writer.